+

WO2006002022A3 - Compositions and methods useful for the treatment of hyperglycemia - Google Patents

Compositions and methods useful for the treatment of hyperglycemia Download PDF

Info

Publication number
WO2006002022A3
WO2006002022A3 PCT/US2005/020724 US2005020724W WO2006002022A3 WO 2006002022 A3 WO2006002022 A3 WO 2006002022A3 US 2005020724 W US2005020724 W US 2005020724W WO 2006002022 A3 WO2006002022 A3 WO 2006002022A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
hyperglycemia
compositions
methods useful
provides
Prior art date
Application number
PCT/US2005/020724
Other languages
French (fr)
Other versions
WO2006002022A2 (en
Inventor
Mirta Grifman
Henry Li
James E Macdonald
Flossie Wong-Staal
Original Assignee
Immusol Inc
Mirta Grifman
Henry Li
James E Macdonald
Flossie Wong-Staal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immusol Inc, Mirta Grifman, Henry Li, James E Macdonald, Flossie Wong-Staal filed Critical Immusol Inc
Publication of WO2006002022A2 publication Critical patent/WO2006002022A2/en
Publication of WO2006002022A3 publication Critical patent/WO2006002022A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention provides compositions and methods for the treatment of disorders characterized by hyperglycemia, in particular, Type II diabetes. The invention also provides a method for identifying novel compositions useful for the treatment of such disorders.
PCT/US2005/020724 2004-06-15 2005-06-10 Compositions and methods useful for the treatment of hyperglycemia WO2006002022A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57961504P 2004-06-15 2004-06-15
US60/579,615 2004-06-15

Publications (2)

Publication Number Publication Date
WO2006002022A2 WO2006002022A2 (en) 2006-01-05
WO2006002022A3 true WO2006002022A3 (en) 2009-04-09

Family

ID=35782242

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/020724 WO2006002022A2 (en) 2004-06-15 2005-06-10 Compositions and methods useful for the treatment of hyperglycemia

Country Status (1)

Country Link
WO (1) WO2006002022A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2243494A1 (en) * 2009-04-22 2010-10-27 OntoChem GmbH Pharmaceutical composition, comprising a steroid-dehydrogenase-reductase inhibitor, and a mineralocorticoid receptor antagonist.
US9241944B2 (en) * 2010-06-16 2016-01-26 Institut National De La Santé Et De La Recherche Médicale (Inserm) Methods and compositions for stimulating reepithelialisation during wound healing
ES2984281T3 (en) 2015-03-03 2024-10-29 Richard W Yee Compositions comprising an aldosterone antagonist for use in the treatment of dry eyes
WO2024245930A2 (en) * 2023-05-26 2024-12-05 E-Therapeutics Plc Inhibitors of expression and/or function

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329534B1 (en) * 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6586416B2 (en) * 2001-04-19 2003-07-01 James K. Bubien Methods of treatment using an epithelial sodium channel blocker and an inhibitor of the mineralocorticoid receptor
US20050054712A1 (en) * 2002-03-15 2005-03-10 Grese Timothy Alan Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329534B1 (en) * 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6586416B2 (en) * 2001-04-19 2003-07-01 James K. Bubien Methods of treatment using an epithelial sodium channel blocker and an inhibitor of the mineralocorticoid receptor
US20050054712A1 (en) * 2002-03-15 2005-03-10 Grese Timothy Alan Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KLUMPP. D.A.: "Preparation of 3,3-Diaryloxindoles by Superacid-Induced Condensation", J. ORG. CHEM., vol. 63, 1998, pages 4481 - 4484, XP002244340, DOI: doi:10.1021/jo980588g *

Also Published As

Publication number Publication date
WO2006002022A2 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
WO2005011592A3 (en) Substituted indazole-o-glucosides
WO2005012243A3 (en) Substituted indole-o-glucosides
TW200608961A (en) Methods and reagents for the treatment of metabolic disorders
WO2005103076A3 (en) Erythropoietin protein variants
WO2005094440A3 (en) Nanofiber surface based capacitors
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2008070692A8 (en) Bicyclic compounds and use as antidiabetics
AU2006268374A8 (en) Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation
WO2005041752A3 (en) Bone plate and method for using bone plate
WO2008058269A3 (en) Compounds and methods for modulating protein trafficking
WO2007014373A3 (en) Novel cells, compositions, and methods
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
PL1694354T3 (en) Method for preventing and treating diabetes using neurturin
WO2005117938A3 (en) Methods of treating ocular conditions
WO2006078998A3 (en) Methods and compositions for decreasing saliva production
WO2005039626A3 (en) Use of hydroxylated amino acids for treating diabetes
WO2007101063A3 (en) Treatment of development-related disorders
WO2009137795A3 (en) Methods for treating endoplasmic reticulum (er) stress disorders
WO2007009887A3 (en) Preparation containing barium sulfate
WO2006042745A3 (en) Chemically modified peptide analogs
WO2006053315A3 (en) Methods and compositions for treating cellular proliferative diseases
WO2006050458A3 (en) Tadalafil crystal forms and processes for preparing them
WO2006002022A3 (en) Compositions and methods useful for the treatment of hyperglycemia
WO2006024958A3 (en) Cannabinoid compositions and methods of use thereof
WO2006000850A3 (en) Method and apparatus for indicating truncated email information in email synchronization

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05760371

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载